3p14 De Novo Interstitial Microdeletion in a Patient with Intellectual Disability and Autistic Features with Language Impairment: A Comparison with Similar Cases.
de la Hoz AB, Maortua H, García-Rives A, Martínez-González MJ, Ezquerra M, Tejada MI.
Case Rep Genet. 2015; 2015: 876348-0. FI: 0.000 (Q0).
Vector analysis of astigmatism correction after tonic intraocular lens implantation.
Krall EM, Arlt EM, Hohensinn M, Moussa S, Jell G, Alio JL, Plaza-Puche AB, Bascaran L, Mendicute J, Grabner G, Dexl AK.
J. Cataract. Refract. Surg. 2015; 41: 790-799. FI: 2.722 (Q1).
Objective Optical Quality Analysis Using Double-Pass Technique in Pterygium Surgery.
Goni N, Bidaguren A, Macias-Murelaga B, Alberdi T, Martinez-Soroa I, Mendicute J.
Cornea. 2015; 34: 60-64. FI: 2.042 (Q2).
Genetic High Throughput Screening in Retinitis Pigmentosa based on High Resolution Melting (HRM) Analysis.
Anasagasti A, Barandika O, Irigoyen C, Benitez BA, Cooper B, Cruchaga C, López de Munain A, Ruiz-Ederra J.
Exp Eye Res. 2013; 116: 386-394. FI: 3.017 (Q1).
In situ fluorescence measurement of tear film [Na+], [K+], [Cl-], and pH in mice shows marked hypertonicity in aquaporin-5 deficiency.
Ruiz-Ederra J, Levin MH, Verkman AS.
Invest Ophth Vis Sci. 2009; 50: 2132-2138. FI: 3.661 (Q1).
Aquaporin-1-facilitated keratocyte migration in cell culture and in vivo corneal wound healing models.
Ruiz-Ederra J, Verkman AS.
Exp Eye Res. 2009; 89: 159-165. FI: 3.017 (Q1).
Needle-guided intrascleral fixation of posterior chamber intraocular lens for aphakia correction.
Rodríguez-Agirretxe I, Acera-Osa A, Ubeda-Erviti M.
J Cataract Refract Surg. 2009; 35: 2051-2053. FI: 2.552 (Q1).
Changes in tear protein profile in keratoconus disease.
Acera A, Vecino E, Rodríguez-Agirretxe I, Aloria K, Arizmendi JM, Morales C, Durán JA.
Eye (Lond). 2011; 25: 1225-1233. FI: 1.897 (Q2).
Rotational stability and visual quality in eyes with Rayner toric intraocular lens implantation.
Alberdi T, Macías-Murelaga B, Bascarán L, Goñi N, de Arregui SS, Mendicute J.
J Refract Surg. 2012; 28 (10): 696-701. FI: 2.781 (Q1).
Current mutation discovery approaches in Retinitis Pigmentosa.
Anasagasti A, Irigoyen C, Barandika O, López de Munain A, Ruiz-Ederra J.
Vision Res. 2012; 75: 117-29. FI: 2.381 (Q2).
Efficacy and stability of AT TORBI 709 M toric IOL.
Bascaran L, Mendicute J, Macias-Murelaga B, Arbelaitz N, Martinez-Soroa I.
J Refract Surg. 2013; 29 (3): 194-199. FI: 2.781 (Q1).
Acute idiopathic blind spot enlargement syndrome associated with choroidal neovascularization.
Macías-Murelaga B, Rodriguez-Agirretxe I, Bascarán L, Goñi N, Mendicute J.
Arch Soc Esp Oftalmol. 2013; 88 (11): 450-452. FI: 0.000 (Q0).
